Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides.
about
Design and pre-clinical evaluation of a universal HIV-1 vaccineBorna disease virus nucleoprotein (p40) is a major target for CD8(+)-T-cell-mediated immune responseThe selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic dosesViral immune evasion due to persistence of activated T cells without effector functionIdentifying Individual T Cell Receptors of Optimal Avidity for Tumor AntigensEnvelope exchange for the generation of live-attenuated arenavirus vaccinesStructural and Functional Correlates of Enhanced Antiviral Immunity Generated by Heteroclitic CD8 T Cell EpitopesTherapeutic DNA vaccine induces broad T cell responses in the gut and sustained protection from viral rebound and AIDS in SIV-infected rhesus macaquesComprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the ImmunopeptidomeDNA vaccines against human immunodeficiency virus type 1.Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in miceThe contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positionsCD4+ T cell subset differentiation and avidity setpoint are dictated by the interplay of cytokine and antigen mediated signalsRecall T cell responses to bluetongue virus produce a narrowing of the T cell repertoireUnmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigenEpitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective Efficacy.Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques.Synergistic enhancement of CD8+ T cell-mediated tumor vaccine efficacy by an anti-transforming growth factor-beta monoclonal antibody.Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice.Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences.Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimenAnaplasma marginale type IV secretion system proteins VirB2, VirB7, VirB11, and VirD4 are immunogenic components of a protective bacterial membrane vaccine.Altered function in CD8+ T cells following paramyxovirus infection of the respiratory tract.Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections.HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the otherThe specificity of trimming of MHC class I-presented peptides in the endoplasmic reticulum.The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells.Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infectionIdentification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motifExperimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65).Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine designA novel CD8-independent high-avidity cytotoxic T-lymphocyte response directed against an epitope in the phosphoprotein of the paramyxovirus simian virus 5Molecular and functional dissection of the H-2Db-restricted subdominant cytotoxic T-cell response to lymphocytic choriomeningitis virus.T-cell proliferation in vivo and the role of cytokinesCoverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model systemContribution of T cell receptor affinity to overall avidity for virus-specific CD8+ T cell responsesProtective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challenges
P2860
Q21092234-6FFAA134-43D7-48D1-9503-042EEC4238E1Q24517045-35C0A664-1FB9-4704-B5C1-05F55E68AD08Q24645843-C8DD8521-EB92-4B4A-970D-56BB9B3526CDQ24646943-46A669CF-C299-4962-BA1A-DF5CB2B47505Q26774669-05DDDB34-FADD-4475-8086-56012555EB70Q27320211-C5F32BCC-4AB7-4C02-996F-F8066D5A3814Q27683638-84361A1C-B160-41F0-8D8D-D33B43D153E1Q28481573-A942797F-B1A9-4D47-A628-D801578D117AQ28548093-11A3CA7D-F53C-4162-A10F-FDA16B69A6A3Q30342130-CB27F8FE-BC6F-41C3-A921-85607A8CFDBCQ30375085-352F5ABA-63D2-4634-A4EC-F3228F0A093CQ30444065-ADE0301E-AA20-4E5B-B9FF-DEDD48017148Q30448796-BC5A99FD-AFDD-4E4A-9B1D-C15495BD912FQ31166277-5478D828-BFFD-4B45-8566-165BE28477B3Q32178442-B6C00CD1-16A1-4D17-9BCA-6813863FB5CEQ33322422-4964DFEA-861A-4E75-A180-EEF1404957E1Q33349793-CFB19D16-913E-4800-A49F-AE19D4F8DB11Q33567970-5612A559-4B70-4268-A084-A2D944F886A2Q33578049-1C5F5048-B510-4705-97DF-19088379AD3BQ33581597-696F5272-3B84-41A3-B4DC-499C9C85B9E1Q33609436-FA770372-4E75-4D8A-8082-DB07FAF63141Q33615145-A5A0A3F6-2E57-4587-861E-984E5A4F7912Q33649842-FA31051A-2049-4E97-9788-40083FF0EEC2Q33676020-417FB8F7-5015-487A-8B40-54E19DA7247DQ33737608-E7C5E37C-D790-4E09-8EAF-A6F7446FCF5DQ33776155-C1622552-A9A4-4C00-97BC-2840EF4F34E5Q33787144-773B5394-7497-4A06-AD35-47554B9FE763Q33791476-26A89C22-3A26-4B25-A962-DA4A87763E74Q33797749-307EBEDA-A0D4-4E43-BAB8-9EE1190F1EF2Q33805975-4E011BD8-D87E-449C-9713-5FF7CEFD8D9EQ33828583-3F46FD19-B035-4F25-8785-AE558E5ED412Q33836117-26B286F9-E0F5-4292-9598-F8D8E0C13B97Q33843590-7CC007E7-818E-4978-90F1-76CFD0572BD3Q33845527-46AFADF2-009D-4080-8ABB-A294B900C7CAQ33847428-CF1BCB56-7C78-421A-BF1F-665EF81524D1Q33850918-50F09218-8017-47F3-9E24-6D35E8C0E423Q33905191-9F8D4631-EBD9-4135-9546-10FD491D12AAQ33909096-0DBAC0C5-4C2D-49F7-A4F5-91A641BA63EAQ33914114-27598013-76C5-4C01-8F9E-4E14B12F76CCQ33916635-57D8AA9A-F0B5-4408-B31C-26484D32CC8B
P2860
Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Protective immunity does not c ...... naturally processed peptides.
@ast
Protective immunity does not c ...... naturally processed peptides.
@en
type
label
Protective immunity does not c ...... naturally processed peptides.
@ast
Protective immunity does not c ...... naturally processed peptides.
@en
prefLabel
Protective immunity does not c ...... naturally processed peptides.
@ast
Protective immunity does not c ...... naturally processed peptides.
@en
P2093
P2860
P356
P1476
Protective immunity does not c ...... naturally processed peptides.
@en
P2093
Gallimore A
Hengartner H
Rammensee HG
Zinkernagel RM
P2860
P304
P356
10.1084/JEM.187.10.1647
P407
P577
1998-05-01T00:00:00Z